0000899243-21-007279.txt : 20210218
0000899243-21-007279.hdr.sgml : 20210218
20210218212504
ACCESSION NUMBER: 0000899243-21-007279
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210216
FILED AS OF DATE: 20210218
DATE AS OF CHANGE: 20210218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vera Juan
CENTRAL INDEX KEY: 0001755495
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39409
FILM NUMBER: 21651826
MAIL ADDRESS:
STREET 1: 2925 RICHMOND AVENUE
STREET 2: SUITE 1274
CITY: HOUSTON
STATE: TX
ZIP: 77098
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Allovir, Inc.
CENTRAL INDEX KEY: 0001754068
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 831971007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 139 MAIN STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 433-2605
MAIL ADDRESS:
STREET 1: 139 MAIN STREET, SUITE 500
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: ViraCyte, Inc.
DATE OF NAME CHANGE: 20180924
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-16
0
0001754068
Allovir, Inc.
ALVR
0001755495
Vera Juan
C/O ALLOVIR, INC.
139 MAIN STREET, SUITE 500
CAMBRIDGE
MA
02142
1
0
0
0
Common Stock
2021-02-16
4
S
0
9434
41.7939
D
2457536
D
Common Stock
2021-02-16
4
S
0
966
42.5273
D
2456570
D
Common Stock
2021-02-17
4
S
0
2000
38.7103
D
2454570
D
Common Stock
2021-02-17
4
S
0
1400
40.0019
D
2453170
D
Common Stock
2021-02-17
4
S
0
4060
41.2578
D
2449110
D
This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 3, 2020.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $41.20 to $42.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $42.25 to $43.13. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $38.21 to $39.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $39.54 to $40.47. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $40.73 to $41.71. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
/s/ Brett Hagen, as Attorney-in-Fact
2021-02-18